Clinical Trial Update: Prognostic Role of Circulating Tumor DNA in Resectable Pancreatic Cancer

View source ↗

Summary

The document describes a clinical trial evaluating whether circulating tumor DNA can serve as a prognostic biomarker in resectable pancreatic cancer. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Pancreas Cancer | Status: ACTIVE_NOT_RECRUITING